Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my primary fiduciary and ethical duty is to patients, regulators, and long-term shareholder value. The "6-month reporting timeline" cited by legal is almost certainly a misunderstanding of regulatory processes (likely conflating initial adverse event reporting with full label amendment review).Read the full answer
This is a high-stakes crisis requiring decisive, legally compliant, ethically grounded, and strategically coordinated action. Below is a structured, hour-by-hour executive playbook for the next 48 hours, followed by cross-cutting rationale addressing your specified dimensions.Read the full answer